CIK 0001799191 · Accelerated filer<br>Smaller reporting company
Starling Oncology, Inc.
Sign in to watch- Tickers
- STLN DFPH
- Exchange
- Nasdaq, OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 843562323
- Phone
- 562-735-3226
- Business address
- 18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
- Former names
- Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.
Securities
- STLN Common Stock Nasdaq
- STLNW Warrant Nasdaq
- DFPH Common stock OTC
- 4 Open-market buy 10% owner bought 18,000 shares at $5.27 ($94,860)
- 4 Planned sale Chief Medical Officer sold 23,452 shares at an average $6.41 ($150,340)
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 15,000 shares at $5.85 ($87,750)
- 4 Grant or award Director acquired 17,185 shares (grant or award)
- 4 Grant or award Director acquired 25,833 shares (grant or award)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure
- 4 Open-market buy 10% owner bought 18,000 shares at $5.02 ($90,360)
- 8-K Event Shareholder vote results
- 4 Planned sale Chief Medical Officer sold 23,451 shares at $5.38 ($126,094)
- 144 Insider Sale of Securities
- 4 Open-market buy 10% owner bought 12,000 shares at $4.75 ($57,000)
- 4 Other disposition Chief Medical Officer disposed of 1,805 shares (other)
- 4 Other disposition Chief Executive Officer disposed of 23,058 shares (other)
- 4 Other disposition Chief Financial Officer disposed of 1,604 shares (other)
- 8-K Event Cybersecurity incident
- 4 Open-market buy 10% owner bought 38,500 shares at an average $4.07 ($156,595)
- 4 Open-market buy 10% owner bought 30,000 shares at $4.09 ($122,700)
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 8-K Event Results of operations
Page 2 of 28 · 548 filings